The cost of population screening and treatment would not be recovered in reduced dyspepsia costs in the lifetime of those screened.
These costs could be reduced substantially if knowledge about their use for different conditions related to dyspepsia would be fully utilized in clinical practice.
A qualitative investigation of health beliefs relating to dyspepsia.
The total sales volume of proton pump inhibitors for the group with dyspepsia exceeded 1.3 billion in 1998.
The parasites can produce morbidity with symptoms like abdominal pain, dyspepsia and fatigue.
During a 3-month period, nearly 30% of the adult population reported dyspepsia.
Economic evaluation of dyspepsia management in primary care management of dyspeptic patients: 6.7 year follow up of a randomised trial.
Symptom relief from functional dyspepsia can be achieved by antacids when the problems have a dominant element of reflux of acid into the esophagus.
